MORREALE, Ilaria
 Distribuzione geografica
Continente #
NA - Nord America 629
EU - Europa 303
AS - Asia 105
SA - Sud America 5
AF - Africa 4
Totale 1.046
Nazione #
US - Stati Uniti d'America 629
IT - Italia 157
CN - Cina 60
FI - Finlandia 43
UA - Ucraina 29
SG - Singapore 25
IE - Irlanda 17
DE - Germania 16
RU - Federazione Russa 13
FR - Francia 9
TR - Turchia 7
GB - Regno Unito 6
BR - Brasile 5
IR - Iran 5
KR - Corea 5
BE - Belgio 4
CI - Costa d'Avorio 4
RO - Romania 3
SE - Svezia 3
HK - Hong Kong 2
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
MK - Macedonia 1
Totale 1.046
Città #
Chandler 75
Fairfield 60
Woodbridge 49
Ashburn 44
Ann Arbor 40
Wilmington 31
Houston 27
Des Moines 23
Palermo 23
Boardman 22
Cambridge 22
Seattle 22
New York 19
Singapore 18
Dublin 17
Medford 17
Jacksonville 16
Milan 11
Nanjing 11
Princeton 11
Venice 11
Santa Clara 10
Dearborn 9
Bologna 8
Altamura 7
Izmir 7
Napoli 7
Rome 7
Lawrence 6
Falls Church 5
Shenyang 5
Tulsa 5
Abidjan 4
Brussels 4
Cagliari 4
Guangzhou 4
Helsinki 4
Ludwigshafen am Rhein 4
Ningbo 4
San Diego 4
Beijing 3
Changsha 3
Frankfurt am Main 3
Genoa 3
Haikou 3
Hebei 3
Jiaxing 3
Lanzhou 3
Orange 3
Phoenix 3
San Paolo di Civitate 3
Tianjin 3
Agrigento 2
Bolzaneto 2
Cesena 2
Columbus 2
Genova 2
Hangzhou 2
Hong Kong 2
Nanchang 2
Padova 2
Pomigliano d'Arco 2
Santarém 2
Seongnam 2
Sesto Calende 2
Taizhou 2
Torino 2
Ardea 1
Arzano 1
Auburn Hills 1
Bremen 1
Brescia 1
Busseto 1
Castellammare di Stabia 1
Cedar Knolls 1
Chengdu 1
Council Bluffs 1
Dallas 1
Dalmine 1
Durham 1
Edinburgh 1
Foggia 1
Fuzhou 1
Hefei 1
Hounslow 1
Jinan 1
Kiev 1
Kunming 1
Lappeenranta 1
Mandanici 1
Mola Di Bari 1
Moscow 1
Norwalk 1
Nürnberg 1
Redwood City 1
Reggio Emilia 1
Saint Petersburg 1
San Francisco 1
San Mateo 1
Santa Flavia 1
Totale 776
Nome #
Medication-related osteonecrosis of the jaw in a cancer patient receiving lenvatinib 153
Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients? 148
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 130
Farmacovigilanza in oncologia: la nostra esperienza nel "Centro di consulenza ed informazione sugli effetti tossici da farmaci antitumorali e sulle ADR in pazienti neoplastici" della Regione Sicilia 122
USE OF HERBAL REMEDIES AMONG CANCER AND TRANSPLANT PATIENTS IN THE TOWN OF PALERMO, SICILY 101
Findings of osteonecrosis of the jaw under combined bisphosphonate and antiangiogenic therapies: an emergent problem? 93
Use of herbal products among cancer and transplanted patients in the town of Palermo,Sicily. 79
La segnalazione delle reazioni avverse da farmaci in oncologia: considerazioni di base e analisi dell'esperienza organizzativa e scientifica nella Regione Sicilia. 72
Protocol of BRONJ prevention: successful use of antiseptics during oral surgical procedures 69
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature 52
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 48
Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines 31
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019–2021) 7
Totale 1.105
Categoria #
all - tutte 3.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.982


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020191 0 0 0 32 31 26 22 18 17 11 30 4
2020/2021159 9 5 20 11 4 16 8 1 24 32 18 11
2021/2022134 16 17 4 6 9 7 9 8 19 12 2 25
2022/2023202 17 33 14 27 17 33 21 10 23 1 6 0
2023/2024129 5 13 10 7 9 21 6 14 0 1 2 41
2024/202576 5 33 22 16 0 0 0 0 0 0 0 0
Totale 1.105